BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33723002)

  • 1. Regulating Polθ in Breast Cancer.
    Carvajal-Maldonado D; Wood RD
    Cancer Res; 2021 Mar; 81(6):1441-1442. PubMed ID: 33723002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMT Transcription Factor ZEB1 Represses the Mutagenic POLθ-Mediated End-Joining Pathway in Breast Cancers.
    Prodhomme MK; Pommier RM; Franchet C; Fauvet F; Bergoglio V; Brousset P; Morel AP; Brunac AC; Devouassoux-Shisheboran M; Petrilli V; Moyret-Lalle C; Hoffmann JS; Puisieux A; Tissier A
    Cancer Res; 2021 Mar; 81(6):1595-1606. PubMed ID: 33239429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential requirements for distinct Polθ domains during theta-mediated end joining.
    Fijen C; Drogalis Beckham L; Terino D; Li Y; Ramsden DA; Wood RD; Doublié S; Rothenberg E
    Mol Cell; 2024 Apr; 84(8):1460-1474.e6. PubMed ID: 38640894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymerase theta-helicase promotes end joining by stripping single-stranded DNA-binding proteins and bridging DNA ends.
    Schaub JM; Soniat MM; Finkelstein IJ
    Nucleic Acids Res; 2022 Apr; 50(7):3911-3921. PubMed ID: 35357490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic determinants of cellular addiction to DNA polymerase theta.
    Feng W; Simpson DA; Carvajal-Garcia J; Price BA; Kumar RJ; Mose LE; Wood RD; Rashid N; Purvis JE; Parker JS; Ramsden DA; Gupta GP
    Nat Commun; 2019 Sep; 10(1):4286. PubMed ID: 31537809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite Roles for ZEB1 and TMEJ in the Regulation of Breast Cancer Genome Stability.
    Prodhomme MK; Péricart S; Pommier RM; Morel AP; Brunac AC; Franchet C; Moyret-Lalle C; Brousset P; Puisieux A; Hoffmann JS; Tissier A
    Front Cell Dev Biol; 2021; 9():727429. PubMed ID: 34458275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Templated Insertions: A Smoking Gun for Polymerase Theta-Mediated End Joining.
    Schimmel J; van Schendel R; den Dunnen JT; Tijsterman M
    Trends Genet; 2019 Sep; 35(9):632-644. PubMed ID: 31296341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polθ Inhibition: An Anticancer Therapy for HR-Deficient Tumours.
    Barszczewska-Pietraszek G; Drzewiecka M; Czarny P; Skorski T; Śliwiński T
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymerase θ Coordinates Multiple Intrinsic Enzymatic Activities during DNA Repair.
    Zahn KE; Jensen RB
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Template and primer requirements for DNA Pol θ-mediated end joining.
    He P; Yang W
    Proc Natl Acad Sci U S A; 2018 Jul; 115(30):7747-7752. PubMed ID: 29987024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Polymerase Theta (POLθ) for Cancer Therapy.
    Patterson-Fortin J; D'Andrea AD
    Cancer Treat Res; 2023; 186():285-298. PubMed ID: 37978141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism, cellular functions and cancer roles of polymerase-theta-mediated DNA end joining.
    Ramsden DA; Carvajal-Garcia J; Gupta GP
    Nat Rev Mol Cell Biol; 2022 Feb; 23(2):125-140. PubMed ID: 34522048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic Lethality Targeting Polθ.
    Drzewiecka M; Barszczewska-Pietraszek G; Czarny P; Skorski T; Śliwiński T
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the mutation signatures of DNA polymerase θ in cancer genomes.
    Hwang T; Reh S; Dunbayev Y; Zhong Y; Takata Y; Shen J; McBride KM; Murnane JP; Bhak J; Lee S; Wood RD; Takata KI
    NAR Cancer; 2020 Sep; 2(3):zcaa017. PubMed ID: 32885167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymerase θ-helicase efficiently unwinds DNA and RNA-DNA hybrids.
    Ozdemir AY; Rusanov T; Kent T; Siddique LA; Pomerantz RT
    J Biol Chem; 2018 Apr; 293(14):5259-5269. PubMed ID: 29444826
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanistic basis for microhomology identification and genome scarring by polymerase theta.
    Carvajal-Garcia J; Cho JE; Carvajal-Garcia P; Feng W; Wood RD; Sekelsky J; Gupta GP; Roberts SA; Ramsden DA
    Proc Natl Acad Sci U S A; 2020 Apr; 117(15):8476-8485. PubMed ID: 32234782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of microhomology-mediated end-joining promoted by human DNA polymerase θ.
    Kent T; Chandramouly G; McDevitt SM; Ozdemir AY; Pomerantz RT
    Nat Struct Mol Biol; 2015 Mar; 22(3):230-7. PubMed ID: 25643323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational signatures of non-homologous and polymerase theta-mediated end-joining in embryonic stem cells.
    Schimmel J; Kool H; van Schendel R; Tijsterman M
    EMBO J; 2017 Dec; 36(24):3634-3649. PubMed ID: 29079701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Scars Generated by Polymerase Theta Reveal the Versatile Mechanism of Alternative End-Joining.
    van Schendel R; van Heteren J; Welten R; Tijsterman M
    PLoS Genet; 2016 Oct; 12(10):e1006368. PubMed ID: 27755535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA polymerase θ (POLQ) is important for repair of DNA double-strand breaks caused by fork collapse.
    Wang Z; Song Y; Li S; Kurian S; Xiang R; Chiba T; Wu X
    J Biol Chem; 2019 Mar; 294(11):3909-3919. PubMed ID: 30655289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.